Alleviant Medical raises $75 million for clinical trials of novel technology to treat heart failure
Medical and Pharma Insider
Medical - Pharma - Biotech - Medical Devices - Healthcare - Telemedicine - Healthcare Technology - Healthcare IT
Your Source For Worldwide Business and Financial Opportunities
-
MedNews on financings, strategic relationships, products, services and technology, including launches
-
MedTalks videos featuring conversations with management of companies with business or financial objectives
.jpg)
Clinical
Trials





- May 26
- 4 min
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharma to develop therapy for Parkinsons


- May 19
- 3 min
Acurx Pharmaceuticals prices $4 million placement to advance its new class of antibiotics


- May 15
- 2 min
Sealonix raises $20 Million to develop sealants for abdominopelvic and orthopedic procedures


- May 12
- 6 min
Regentis Biomaterials to become listed on Nasdaq through a SPAC transaction


- May 11
- 3 min
Lexaria Bioscience prices $2 million public offering - proceeds to advance drug delivery technology

- May 10
- 4 min
Pressure BioScience’s Pressure-Based Tech Is Ready To Spur Innovation And Growth In Life Sciences

- May 3
- 4 min
Plus Therapeutics and Piramal Pharma Solutions expand collaboration for clinical trials


- Apr 25
- 2 min
ANI Pharmaceuticals obtains FDA Approval and launches its Nitrofurantoin Oral Suspension USP


- Apr 19
- 2 min
Medical device company, BioVentrix closes on $48.5 million to improve cardiac function


- Apr 18
- 4 min
Aer Therapeutics raises $36 Million to advance development of a mucolytic for lung diseases

- Apr 14
- 4 min
Novo Holdings participates in $105 million funding in Alentis Therapeutics

- Apr 3
- 3 min
Orion is building a pharmaceutical research ecosystem using data and artificial intelligence


- Mar 30
- 3 min
Viking Therapeutics prices $250 Million public common stock offering


- Mar 4
- 3 min
Prana Thoracic raises $3 million to advance its lung tissue excision tool for lung cancer


- Mar 2
- 6 min
Mitsubishi Tanabe Pharma America announces preliminary results from Phase 3 ALS Trial

- Feb 24
- 5 min
Transcend Therapeutics, a mental health-focused biotechnology company, closes on $40 million


- Feb 13
- 2 min
Quotient Sciences expands its early-phase formulation development capabilities for oral dosage forms


- Feb 1
- 4 min
Panbela prices $15 million public offering


- Jan 18
- 2 min
To address patient demand, SFJ Pharmaceuticals closes the acquisition of Bentracimab


- Jan 4
- 3 min
Apnimed Closes $79.75 Million for Phase 3 Trials of an Oral Medication for Obstructive Sleep Apnea

- Dec 27, 2022
- 2 min
Ablaze Pharmaceuticals and Yonghe Pharma to develop targeted radiopharma therapies


- Dec 22, 2022
- 4 min
University Hospitals Performs First Arthroscopic Surgeries in Ohio using ArthroFree Wireless Camera


- Nov 23, 2022
- 3 min
scPharmaceuticals Announces Pricing of $50 Million Public Offering


- Nov 5, 2022
- 3 min
H.I.G. Capital acquires leading global clinical research organization Celerion


- Oct 15, 2022
- 4 min
Integrated Drug Development Solution Company Altasciences Expands Support for Early Drug Development


- Oct 8, 2022
- 4 min
RadioMedix raises $40 million to advance its alpha therapy platform for oncology


- Oct 2, 2022
- 4 min
CXL Ophthalmics announces $32 Million investment to advance its treatment for keratoconus

- Sep 28, 2022
- 3 min
Aqualung Therapeutics Receives FDA Clearance of its IND for Acute Respiratory Distress Syndrome

- Sep 27, 2022
- 2 min
SeraNovo and Ildong Pharmaceutical to Collaborate on Multi-Compound Research Projects


- Sep 1, 2022
- 3 min
OKYO plans fourth quarter IND filing for drug candidate to treat dry eye disease


- Aug 13, 2022
- 2 min
Clario invests in new technology to reduce translation times for clinical trials


- Aug 5, 2022
- 2 min
Immunis Closes $10 Million to advance its immunomodulatory secretome product for muscle atrophy

- Aug 3, 2022
- 3 min
IDRx raises $122 million to transform cancer treatment with precision combination therapies


- Jul 29, 2022
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses


- Jul 11, 2022
- 3 min
FIRST IN HUMAN SUBJECTS ENROLLED IN AQUALUNG THERAPEUTICS PHASE 1A STUDY OF ALT-100


- Jul 9, 2022
- 4 min
Kernal Biologics Raises $25 Million to Advance its mRNA 2.0 Technology for Oncology


- Jun 5, 2022
- 3 min
Imaging Endpoints and ImaginAb partner to supply doses of the CD8 imaging agent for clinical trials


- May 14, 2022
- 7 min
Mitsubishi Tanabe Pharma America obtains FDA approval of its RADICAVA ORS for the treatment of ALS

- May 7, 2022
- 2 min
Sen-Jam Pharmaceutical Enrolls Patients in its COVID Therapy Phase 2 Clinical Trial

- May 4, 2022
- 3 min
Four pharma solution providers launch Norstella to provide faster patient access to therapies

- Apr 15, 2022
- 4 min
With new funding, Pictor partners with Mobility Health for a SARS-CoV-2 antibody test

- Apr 7, 2022
- 2 min
ENDOVASCULAR ENGINEERING CLOSES ON $15 MILLION FOR VENOUS THROMBECTOMY SOLUTIONS


- Mar 26, 2022
- 3 min
Geneos Therapeutics closes on $17 million to advance its personalized cancer immunotherapy platform


- Mar 24, 2022
- 3 min
Sen-Jam Pharmaceutical partners with KVK Tech for Covid oral therapeutic


- Mar 21, 2022
- 3 min
Triumvia Immunologics completes $100 million round for its T cell therapeutics


- Mar 2, 2022
- 2 min
Alcami, the contract development and manufacturer adds formulation development laboratory


- Feb 28, 2022
- 4 min
Algernon Pharmaceuticals starts chronic kidney disease research program

- Feb 19, 2022
- 2 min
Dizal Pharmaceutical obtains FDA Fast Track Designation for its drug for Refractory T-Cell Lymphoma


- Feb 14, 2022
- 5 min
Otsuka and Sunovlon start Phase 3 trials for a treatment for biopolar depression